Dr. Daniel Grosu

Founder & Managing Partner

GENOPRAXIS, LLC.

Dr. Grosu is the Founder and Managing Partner of GENOPRAXIS, LLC. He most recently served as Chief Medical Officer at Sequenom, Inc. until its acquisition by LabCorp, Inc. Previously, Dr. Grosuwas at Illumina, Inc., where he served as the Company’s first Chief Medical Officer. He established the Medical Affairs and Clinical Development functions at Illumina and led the team that performed the clinical studies for the first FDA-cleared and CE-marked next-generation sequencing (NGS) IVD platform and IVD assays. Earlier in his career, Dr. Grosu held positions of increasing responsibility at Siemens Medical Solutions, Bayer HealthCare Pharmaceuticals, and Johnson & Johnson.

He holds an MD (with Distinction in Research) from Saint Louis University School of Medicine (Missouri, USA) and an MBA from the University of Oxford (United Kingdom).

Specialties: Medical affairs, clinical development, technology assessment from a clinical perspective, advising on genomic medicine topics including non-invasive prenatal testing (NIPT), liquid biopsy, and inherited disorders.

Speaker Questionnaire
What is the biggest thing you learned in 2020?

What do you feel are the two most important benefits or areas that need to be a top priority in 2021?

Can you share a story on an area of your healthcare program or employee benefits where you were able to create significant savings or stop costs from rising?

If you could automatically receive a 10-20% reduction in costs in three areas/programs, what would your dream list be?

What is the most innovative program you will focus on in 2021 and/or 2022?

How are you re-imagining corporate culture & well-being?

What virtual care solutions did you roll out during the pandemic? How valuable were they and why?

If you look at our 3 Moonshots - Costs, Culture, and Care; In one sentence, tell us what would be something positive for us to take from 2020 and bring into this new year?

2021 Sponsors

1 Conference. 3 Moonshots.

Costs

Moonshot #1​

Reduce employer healthcare and benefits costs by 25% by 2025.​

LEARN MORE

Culture

Moonshot #2​

Reimagine engagement and well-being.

LEARN MORE

Care

Moonshot #3

Provide 40% of healthcare services virtually and through technology by 2025.​

LEARN MORE
FREE

No Admission Fee!

Participate from your office with a mask...or home without one!

Join us for the 13th HEALTHCARE ЯEVOLUTION®

REGISTER FOR FREE
×